Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO)

CUSIP: 84833T103

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
+125,417
Put/Call ratio
108%
SEC-reported price per share
$16.01
Number of holders
82
Value change
+$1,752,850
Number of buys
26
Open additional details 1 more signal available
Number of sells
32
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
55,705,828

Security key

84833T103

Report period

Q4 2021

Institutions

82

Top holders

10

Ownership snapshot

Top reported holders of SPRO - Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Aquilo Capital Management...
Disclosed value leader
Aquilo Capital Management...
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F Lead comparable stake: 8.2% Showing 1-6 of 15 holder rows.

Quick read

Aquilo Capital Management, LLC leads the comparable SEC ownership view at 8.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Aquilo Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
Aquilo Capital Management, LLC 8.2%
BVF INC/IL 3.2%
BlackRock Finance, Inc. 3.2%
Atlas Venture Associates IX, LLC 2.5%
VANGUARD GROUP INC 2.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Aquilo Capital Management, LLC
13F
Company
13F
8.2%
$84,017,000
4,563,688 shares
30 Sep 2021
BVF INC/IL
13F
Company
13F
3.2%
$33,310,000
1,809,352 shares
30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
3.2%
$33,185,000
1,802,528 shares
30 Sep 2021
Atlas Venture Associates IX, LLC
13F
Company
13F
2.5%
$25,350,000
1,376,968 shares
30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
2.3%
$23,794,000
1,292,498 shares
30 Sep 2021
Rock Springs Capital Management LP
13F
Company
13F
1.7%
$17,334,000
941,543 shares
30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
82
Shares
19,791,141
Rows available
82
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
87
Q4 2021 holders
82
Holder diff
-5
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .